Speciality Medicines Limited (BSE: 544738) is a Mumbai, Maharashtra-based company in the Pharmaceutical Product Distribution industry. With a market capitalisation of ₹149 Cr, it ranks #2,899 by market cap among the 6,197 Indian listed companies on FinBizNet, and #7 of 13 in Pharmaceutical Product Distribution. At ₹169.40 (as of 16 Nov 2026), the share price is 55.6% below its 52-week high of ₹381.20 and 39.9% above its 52-week low of ₹121.10.
| Current Price | ₹169.40 |
|---|---|
| Market Cap | ₹149 Cr |
| BSE Code | 544738 |
| Sector | Health Care > Health Care Equipment and Services > Health Care Providers and Services |
| Sub-Industry | Health Care Distributors > Pharmaceutical Product Distribution |
| P/E Ratio | 11.5 |
| Return on Assets | 12.49% |
| 52-Week Range | ₹121.10 – ₹381.20 |
| 3-Month Price Change | +7.2% |
| Beta (1Y) | 1.46 |
| Headquarters | Mumbai, Maharashtra |
| Website | www.specialitymedicine.com |
Delivery averaged 89.0% of traded volume across 15 BSE sessions (21 Oct 2026 – 13 Nov 2026).
Speciality Medicines Limited engages in the manufacturing, marketing and distribution of finished formulations of specialty pharmaceutical products in India and internationally. The company offers tablets, capsules, cream, syrups, eye drops, gel, infusion, inhalation, inhaler, injection, nasal spray, ointment, ophthalmic, oral solution, oral suspension, sachet, and suspension for oncology, immunology, neurology, and rare diseases therapeutic areas. It also provides patient, hospitals, institutions and NGO supplies, validated controlled supply management, the authenticity of the product by providing documents, warehousing facility, and tracking delivery services. In addition, the company engages in the contract manufacturing business. The company was incorporated in 2021 and is based in Mumbai, India.
1. Wholesale - Drugs-This segment engages in the manufacturing, marketing, trading, and distribution of specialty pharmaceuticals finished formulations and products. 2. NA-NA 3. NA-NA 4. NA-NA
1. Wholesale - Drugs-100%
| Company | Market Cap | P/E | ROE | Latest Qtr Revenue | 1Y Change |
|---|---|---|---|---|---|
| Entero Healthcare Solutions Limited | ₹8,733 Cr | 74.6 | 8.28% | ₹2,087 Cr | +80.7% |
| Remus Pharmaceuticals Limited | ₹941 Cr | 26.1 | 13.78% | — | +0.6% |
| Health X Platform Limited (Sastasundar Ventures Ltd) | ₹871 Cr | 752.7 | -0.18% | ₹484 Cr | -5.7% |
| Aptus Pharma Limited | ₹837 Cr | 156.8 | — | — | +754.0% |
| Vasa Denticity Limited | ₹797 Cr | 76.5 | 6.68% | ₹87 Cr | -21.4% |
| Bijoy Hans Ltd | ₹523 Cr | — | — | — | +128.4% |
| Speciality Medicines Limited | ₹149 Cr | 11.5 | — | — | — |
| Vijaypd Ceutical Limited | ₹136 Cr | 23 | 9.53% | — | — |
| Royal Sense Limited | ₹39 Cr | 5.6 | — | — | -71.2% |
Listed by market capitalisation. Ratios are shown for context only.
Speciality Medicines Limited is trading at ₹169.40, with a market capitalisation of ₹149 Cr.
Speciality Medicines Limited operates in the Health Care > Health Care Equipment and Services > Health Care Providers and Services space (Health Care Distributors > Pharmaceutical Product Distribution).
Speciality Medicines Limited has a P/E of 11.5.
Speciality Medicines Limited is listed on the BSE under the scrip code 544738.
Data as of 16 Nov 2026. Descriptive market data only — not investment advice.